Ventral midbrain neural stem cells have delayed neurogenic potential in vitro.

Typeset version

 

TY  - JOUR
  - Hegarty S.V., Spitere K., O'Keeffe G.W., Sullivan A.M.
  - 2014
  - January
  - Neuroscience Letters
  - Ventral midbrain neural stem cells have delayed neurogenic potential in vitro.
  - Published
  - ()
  - Neural stem cell; Ventral midbrain; Neurogenesis; Differentiation
  - 559
  - 193
  - 198
  - Neural stem cells (NSCs) have been the focus of an intensive effort to direct their differentiation in vitro towards desired neuronal phenotypes for cell replacement therapies. It is thought that NSCs derived from older embryos have limited neurogenic capacity and are restricted towards an astroglial fate. This idea is largely based on studies that typically analysed NSC-derived progeny following one week of in vitro differentiation. In this report, the neurogenic capacity of older ventral midbrain (VM) NSCs was assessed. When the older NSCs were differentiated for three weeks, there were significant increases in the numbers of newly born neurons at 14 and 21 days, as assessed by 5-bromo-2'-deoxyuridine (BrdU) incorporation. Therefore this study demonstrates that older NSCs retain significantly more neurogenic potential than was previously thought. These data have implications for NSC preparatory protocols and the choice of donor age for cell transplantation studies, and contributes to the understanding of NSC behaviour in vitro.
  - http://www.sciencedirect.com/science/article/pii/S0304394013010823
  - 10.1016/j.neulet.2013.12.009
DA  - 2014/01
ER  - 
@article{V286292562,
   = {Hegarty S.V.,  Spitere K. and  O'Keeffe G.W.,  Sullivan A.M. },
   = {2014},
   = {January},
   = {Neuroscience Letters},
   = {Ventral midbrain neural stem cells have delayed neurogenic potential in vitro.},
   = {Published},
   = {()},
   = {Neural stem cell; Ventral midbrain; Neurogenesis; Differentiation},
   = {559},
  pages = {193--198},
   = {{Neural stem cells (NSCs) have been the focus of an intensive effort to direct their differentiation in vitro towards desired neuronal phenotypes for cell replacement therapies. It is thought that NSCs derived from older embryos have limited neurogenic capacity and are restricted towards an astroglial fate. This idea is largely based on studies that typically analysed NSC-derived progeny following one week of in vitro differentiation. In this report, the neurogenic capacity of older ventral midbrain (VM) NSCs was assessed. When the older NSCs were differentiated for three weeks, there were significant increases in the numbers of newly born neurons at 14 and 21 days, as assessed by 5-bromo-2'-deoxyuridine (BrdU) incorporation. Therefore this study demonstrates that older NSCs retain significantly more neurogenic potential than was previously thought. These data have implications for NSC preparatory protocols and the choice of donor age for cell transplantation studies, and contributes to the understanding of NSC behaviour in vitro.}},
   = {http://www.sciencedirect.com/science/article/pii/S0304394013010823},
   = {10.1016/j.neulet.2013.12.009},
  source = {IRIS}
}
AUTHORSHegarty S.V., Spitere K., O'Keeffe G.W., Sullivan A.M.
YEAR2014
MONTHJanuary
JOURNAL_CODENeuroscience Letters
TITLEVentral midbrain neural stem cells have delayed neurogenic potential in vitro.
STATUSPublished
TIMES_CITED()
SEARCH_KEYWORDNeural stem cell; Ventral midbrain; Neurogenesis; Differentiation
VOLUME559
ISSUE
START_PAGE193
END_PAGE198
ABSTRACTNeural stem cells (NSCs) have been the focus of an intensive effort to direct their differentiation in vitro towards desired neuronal phenotypes for cell replacement therapies. It is thought that NSCs derived from older embryos have limited neurogenic capacity and are restricted towards an astroglial fate. This idea is largely based on studies that typically analysed NSC-derived progeny following one week of in vitro differentiation. In this report, the neurogenic capacity of older ventral midbrain (VM) NSCs was assessed. When the older NSCs were differentiated for three weeks, there were significant increases in the numbers of newly born neurons at 14 and 21 days, as assessed by 5-bromo-2'-deoxyuridine (BrdU) incorporation. Therefore this study demonstrates that older NSCs retain significantly more neurogenic potential than was previously thought. These data have implications for NSC preparatory protocols and the choice of donor age for cell transplantation studies, and contributes to the understanding of NSC behaviour in vitro.
PUBLISHER_LOCATION
ISBN_ISSN
EDITION
URLhttp://www.sciencedirect.com/science/article/pii/S0304394013010823
DOI_LINK10.1016/j.neulet.2013.12.009
FUNDING_BODY
GRANT_DETAILS